Gene therapy in glioblastoma multiforme: Can it be a role changer?
Glioblastoma multiforme (GBM) is one of the most lethal cancers with a poor prognosis. Over the past century since its initial discovery and medical description, the development of effective treatments for this condition has seen limited progress. Despite numerous efforts, only a handful of drugs ha...
Main Authors: | Mohammad Rayati, Vahid Mansouri, Naser Ahmadbeigi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024031189 |
Similar Items
-
Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
by: Oleg Mozhei, et al.
Published: (2020-12-01) -
Role of extent of resection on the survival of glioblastoma multiforme
by: Dipak Chaulagain, et al.
Published: (2023-06-01) -
Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma
by: Junsheng Li, et al.
Published: (2021-05-01) -
Current management of glioblastoma multiforme
by: Moscote-Salazar Luís Rafael, et al.
Published: (2010-12-01) -
Editorial: Improving responses to immunotherapy in glioblastoma multiforme
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01)